Literature DB >> 18305129

Identifying infections with respiratory syncytial virus by using specific immunoglobulin G (IgG) and IgA enzyme-linked immunosorbent assays with oral-fluid samples.

Emelda A Okiro1, Charles Sande, Martin Mutunga, Graham F Medley, Patricia A Cane, D James Nokes.   

Abstract

Currently, respiratory syncytial virus (RSV) infection is identified in epidemiological studies by virus antigen or nucleic acid detection in combination with serology. Oral-fluid specimens may provide a noninvasive alternative to blood, and oral fluid is more suitable for sampling outside of the clinic setting. We evaluated an indirect enzyme-linked immunosorbent assay for the detection of RSV-specific immunoglobulin G (IgG) and IgA by using oral-fluid samples collected from individuals with RSV infections confirmed by an immunofluorescent antibody test. For five children sampled repeatedly from birth, antibody profiles in oral fluid quite consistently tracked those in paired sera, and RSV infections were detected by rising titers of antibodies of at least one Ig class. Specific IgG responses were generally more reliable than IgA responses, except in early infancy, where the reverse was sometimes true. For a further five young children from whom oral fluid was collected weekly following RSV infection, boosted antibody responses, frequently of a transient nature, lasting a few weeks, were observed; specific IgG responses were of longer duration and more pronounced than specific IgA responses. Our data show significant promise for the use of oral fluid alone in RSV infection surveillance. The observed rapid dynamics of the antibody responses are informative in defining study sampling intervals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305129      PMCID: PMC2395083          DOI: 10.1128/JCM.02190-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.

Authors:  D J Nokes; F Enquselassie; W Nigatu; A J Vyse; B J Cohen; D W Brown; F T Cutts
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

2.  The elimination of indigenous measles transmission in England and Wales.

Authors:  Mary E Ramsay; Li Jin; Joanne White; Pam Litton; Bernard Cohen; David Brown
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

3.  Estimation of incidence of respiratory syncytial virus infection in schoolchildren using salivary antibodies.

Authors:  S D Wilson; K Roberts; K Hammond; J G Ayres; P A Cane
Journal:  J Med Virol       Date:  2000-05       Impact factor: 2.327

4.  Respiratory syncytial virus infections within families.

Authors:  C B Hall; J M Geiman; R Biggar; D I Kotok; P M Hogan; G R Douglas
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

5.  Respiratory syncytial virus epidemiology in a birth cohort from Kilifi district, Kenya: infection during the first year of life.

Authors:  D James Nokes; Emelda A Okiro; Mwanajuma Ngama; Lisa J White; Rachel Ochola; Paul D Scott; Patricia A Cane; Graham F Medley
Journal:  J Infect Dis       Date:  2004-10-08       Impact factor: 5.226

6.  The immunologic response to infection with respiratory syncytial virus in infants.

Authors:  K McIntosh; H B Masters; I Orr; R K Chao; R M Barkin
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

7.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.

Authors:  F W Henderson; A M Collier; W A Clyde; F W Denny
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

8.  The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.

Authors:  R C Welliver; T N Kaul; T I Putnam; M Sun; K Riddlesberger; P L Ogra
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

9.  Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.

Authors:  D James Nokes; Emelda A Okiro; Mwanajuma Ngama; Rachel Ochola; Lisa J White; Paul D Scott; Michael English; Patricia A Cane; Graham F Medley
Journal:  Clin Infect Dis       Date:  2008-01-01       Impact factor: 9.079

10.  Maternal antibody and respiratory syncytial virus infection in infancy.

Authors:  M M Ogilvie; A S Vathenen; M Radford; J Codd; S Key
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

View more
  5 in total

1.  The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease.

Authors:  E O Ohuma; E A Okiro; R Ochola; C J Sande; P A Cane; G F Medley; C Bottomley; D J Nokes
Journal:  Am J Epidemiol       Date:  2012-10-11       Impact factor: 4.897

2.  Human saliva as a source of anti-malarial antibodies to examine population exposure to Plasmodium falciparum.

Authors:  Patricia Tabernero Estévez; Judith Satoguina; Davis C Nwakanma; Sheila West; David J Conway; Chris J Drakeley
Journal:  Malar J       Date:  2011-04-29       Impact factor: 2.979

3.  Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya.

Authors:  Joyce Uchi Nyiro; Charles Jumba Sande; Martin Mutunga; Patience Kerubo Kiyuka; Patrick Kioo Munywoki; John Anthony G Scott; David James Nokes
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

4.  Duration of shedding of respiratory syncytial virus in a community study of Kenyan children.

Authors:  Emelda A Okiro; Lisa J White; Mwanajuma Ngama; Patricia A Cane; Graham F Medley; D James Nokes
Journal:  BMC Infect Dis       Date:  2010-01-22       Impact factor: 3.090

5.  The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children.

Authors:  Emelda A Okiro; Mwanajuma Ngama; Ann Bett; D James Nokes
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.